Notice Number: NOT-DK-07-001
Release Date: January 23, 2007
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (http://www.niddk.nih.gov)
The National Institute of Diabetes and Digestive Diseases (NIDDK) announces that it is terminating its participation in PA-06-413: Diet, Epigenetic Events, and Cancer Prevention (R21).
The NIDDK is participating in the NIH Exploratory/Developmental Research Grant Program (Parent R21) which may be found at http://grants.nih.gov/grants/guide/pa-files/PA-06-181.html. Information about NIDDK’s R21 program can be found at http://www2.niddk.nih.gov/Funding/Grants/ApplicantGuidelines/R21.htm .
The following Institutes continue to participate in PA-06-413:
National Cancer Institute (NCI), (http://www.nci.nih.gov)
National Institute of Alcohol Abuse and Alcoholism (NIAAA), (http://www.niaaa.nih.gov)
Office of Dietary Supplements (ODS), (http://dietary-supplements.info.nih.gov/)
For questions regarding this specific NIDDK notice please contact:
Michael K. May, Ph.D.
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health
6707 Democracy Boulevard, 2 Democracy Plaza Room 663, MSC 5450
Bethesda, MD 20892-5450 (for U.S. Postal Service express or regular mail)
Bethesda, MD 20817 (for express/courier delivery)
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
Office of Extramural
National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
Department of Health
and Human Services (HHS)